Its therapeutic effects are derived from its ability to inhibit the so-called mammalian target of rapamycin (mTOR) complex and include antifibrotic, cytostatic, antiangiogenic, and anti-lymphangiogenic effects [12] as has been demonstrated in tumors, especially carcinomas and hematologic cancers, as well as in retinal and corneal diseases [13–15]. Here, MTOR is linked to carcinoma.